摘要
绝大多数甲状腺癌预后良好,但局部晚期甲状腺癌的治疗却是一个棘手的问题。随着靶向和免疫治疗的广泛应用,将其用于局部晚期甲状腺癌的新辅助治疗成为新的治疗方向。本文对不同病理类型甲状腺癌相关的新辅助化疗、放疗、靶向及免疫治疗研究进行总结,重点阐述了新辅助治疗中应用靶向及免疫治疗药物的最新进展和思考,为局部晚期甲状腺癌的临床治疗提供更多选择。
The vast majority of thyroid cancers show a good prognosis.However,the treatment of locally advanced thyroid cancer presents a huge problem.The wide application of targeted and immunotherapy in neoadjuvant therapy for locally advanced thyroid cancer has become a new therapeutic direction.This article summarizes the research on neoadjuvant chemotherapy,radiotherapy,and targeted therapy and immunotherapy related to various pathological types of thyroid cancer,with a focus on the recent advancements and thoughts on the application of targeted and immunotherapeutic drugs in neoadjuvant therapy.The results provide additional options for the clinical treatment of locally advanced thyroid cancer.
作者
樊倩妤
黄秋艺
陈健
FAN Qianyu;HUANG Qiuyi;CHEN Jian(Department of Head and Neck Surgery,Hubei Cancer Hospital,The Seventh Clinical School Affiliated of Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430079,China)
出处
《肿瘤防治研究》
CAS
2024年第4期290-295,共6页
Cancer Research on Prevention and Treatment
基金
湖北省肿瘤医院生物医学中心专项科研基金(2022SWZX11)。
关键词
甲状腺癌
新辅助治疗
分子靶向治疗
免疫治疗
Thyroid cancer
Neoadjuvant therapy
Molecular targeted therapy
Immunotherapy
